Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. (INDP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · INDP · as of Sep 30, 2025
Ownership Breakdown
5
Institutional Holders
$57,942
Total Inst. Value
▲ $54,709 vs Q2
1.75M
Shares Outstanding
freeFloat 81.41%
20,022
13F Shares Held
▲ 19,715 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
INDP largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 7 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC pharmaceutical preparations | 19.0K | 87.65% | 87.65% | $55.00M | Nov 14, 2025 | NEW |
UBS GROUP AG pharmaceutical preparations | 502 | 2.32% | 2.32% | $1.44M | Nov 13, 2025 | NEW |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 473 | 2.18% | 2.18% | $1.36M | Nov 14, 2025 | ▲ 365 |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 33 | 0.15% | 0.15% | $94,000 | Feb 3, 2026 | ▲ 2 |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 17 | 0.08% | 0.08% | $49,000 | Nov 5, 2025 | ▼ 139 |
FMR LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2025 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+367 shares2
New Positions
first time holders1
Decreased
−139 shares2
Sold Out
fully exitedNet shares change (top 50)
+228
+367 / −139
Net new holders
+1
2 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
INDP insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
5
Sell transactions
1.20
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Lazar David E. director | Mar 23, 2026 | Sale | 196,800 | — | — | 103.2K | Form 4 ↗ |
Lazar David E. director | Mar 23, 2026 | Sale | 700,000 | — | — | 0 | Form 4 ↗ |
Jabbour Jerome D director | Feb 26, 2026 | Award | 25,000 | $2.06 | $51.5K | 25.0K | Form 4 ↗ |
Meckler Jeffrey A Co-Chief Executive Officer | Feb 11, 2026 | Award | 12,136 | $1.75 | $21.2K | 12.1K | Form 4 ↗ |
Meckler Jeffrey A Co-Chief Executive Officer | Feb 11, 2026 | Award | 3,033 | $1.75 | $5.3K | 3.0K | Form 4 ↗ |
Meckler Jeffrey A Co-Chief Executive Officer | Feb 11, 2026 | Award | 1,519 | $1.75 | $2.7K | 1.5K | Form 4 ↗ |
Meckler Jeffrey A Co-Chief Executive Officer | Feb 11, 2026 | D-Return | 12,136 | $8.30 | $100.7K | 0 | Form 4 ↗ |
Meckler Jeffrey A Co-Chief Executive Officer | Feb 11, 2026 | D-Return | 3,033 | $47.60 | $144.4K | 0 | Form 4 ↗ |
Meckler Jeffrey A Co-Chief Executive Officer | Feb 11, 2026 | D-Return | 1,519 | $29.40 | $44.7K | 0 | Form 4 ↗ |
Ben-Tzvi Avraham director | Jan 20, 2026 | Award | 25,000 | — | — | 25.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Indaptus Therapeutics, Inc. (INDP) is primarily owned by institutional investors, who hold approximately 1.1% of total shares outstanding. Company insiders own approximately 18.59%, while retail and public investors account for the remaining 80.26%.
The largest institutional shareholder of Indaptus Therapeutics, Inc. is VIRTU FINANCIAL LLC, holding approximately 18,997 shares — equal to 87.65% of outstanding shares — as of September 30, 2025.
A total of 5 institutional investors currently hold INDP stock, with a combined institutional value of approximately $57,942 as of the most recent 13F filing period.
Frequently asked questions
INDP ownershipIndaptus Therapeutics, Inc. (INDP) is primarily owned by institutional investors, who hold approximately 1.1% of shares. The largest shareholder is VIRTU FINANCIAL LLC with a 87.65% stake. Company insiders hold 18.59%. Data sourced from SEC Form 13F as of September 30, 2025.